He is an alumnus of the UIC College of Pharmacy where he completed his PharmD before pursuing his MPH in Biostatistics and Epidemiology at New York University and PhD in Epidemiology at the University of Washington. He completed additional training in cancer epidemiology and prevention as postdoctoral fellow at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Calip’s primary research interests are related to comorbidity and treatment-related sequelae among cancer survivors. Dr. Calip is recipient of the Hans W. Vahlteich Research Scholar Award and recently received a grant from the National Institutes of Health, National Heart, Lung and Blood Institute for “Improving Outcomes in Cancer Treatment-Related Cardiotoxicity”.